カテゴリ： MarketLine, アメリカ, 企業調査

Teva Pharmaceuticals USA Inc：企業のM&A・事業提携・投資動向

◆英語タイトル：Teva Pharmaceuticals USA Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード：DATA904C1989
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：235
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD700 ⇒換算￥103,600見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD1,050 ⇒換算￥155,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Teva Pharmaceuticals USA Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Teva Pharmaceuticals USA Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Teva Pharmaceuticals USA Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Teva Pharmaceuticals USA Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Teva Pharmaceuticals USA Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Teva Pharmaceuticals USA Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Teva Pharmaceuticals USA Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Teva Pharmaceuticals USA Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Teva Pharmaceuticals USA Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
PARTNERSHIP 7
Partnership – Overview 7
Partnership – Deal reports 8
DIVESTMENTS 218
Divestments – Overview 218
Divestments – Deal reports 219
APPENDIX 225
Contact Us 225
About MarketLine Financial Deals Database 225
Deal Definition and Methodology 227
About MarketLine 234

List of Tables
Table 1: Teva Pharmaceuticals USA Inc partnership volume and value trend (2014-YTD2018)
Table 2: Teva Pharmaceuticals USA Inc partnership trend by key deal type (2014-YTD2018)
Table 3: Teva Pharmaceuticals USA Inc divestments volume and value trend (2014-YTD2018)
Table 4: Teva Pharmaceuticals USA Inc divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Teva Pharmaceuticals USA Inc partnership volume and value trend (2014-YTD2018)
Figure 2: Teva Pharmaceuticals USA Inc partnership trend by key deal type (2014-YTD2018)
Figure 3: Teva Pharmaceuticals USA Inc divestments volume and value trend (2014-YTD2018)
Figure 4: Teva Pharmaceuticals USA Inc divestments by geography (2014-YTD2018)

★海外企業調査レポート[Teva Pharmaceuticals USA Inc：企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Humana Inc.：企業のM&A・事業提携・投資動向
    Humana Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Humana Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • SAE Towers Holdings LLC：企業の戦略的SWOT分析
    SAE Towers Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Relmada Therapeutics Inc (RLMD)：製薬・医療：M&Aディール及び事業提携情報
    Summary Relmada Therapeutics Inc (Relmada Therapeutics), formerly Camp Nine Inc, is a pharmaceutical company that develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s product pipeline includes REL-1017 d-Methadone, an antagonist for the treat …
  • Russian Aircraft Corporation MiG JSC：企業の戦略・SWOT・財務情報
    Russian Aircraft Corporation MiG JSC - Strategy, SWOT and Corporate Finance Report Summary Russian Aircraft Corporation MiG JSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Integra LifeSciences Holdings Corp (IART)：企業の財務・戦略的SWOT分析
    Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Evgen Pharma Plc (EVG)：製薬・医療：M&Aディール及び事業提携情報
    Summary Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a clinical-stage drug development company that develops clinical pipeline for breast cancer and subarachnoid haemorrhage. The company develops SFX-01 to reduce the vasospasm and incidence of delayed cerebral ischemia which leads t …
  • A&W Food Services of Canada Inc：企業の戦略・SWOT・財務情報
    A&W Food Services of Canada Inc - Strategy, SWOT and Corporate Finance Report Summary A&W Food Services of Canada Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Lietuvos energijos gamyba, AB (LNR1L)-エネルギー分野：企業M&A・提携分析
    Summary Lietuvos energijos gamyba, AB (Lietuvos), a subsidiary of Lietuvos Energija UAB, is a state-controlled electric utility that generates, imports and exports, and supplies electricity and thermal energy. It generates electricity from hydro, thermal and renewable energy sources. The company tra …
  • BYD Co Ltd (1211)-エネルギー分野：企業M&A・提携分析
    Summary BYD Company Limited (BYD) designs, manufactures and sells rechargeable batteries, photovoltaic products, handset components, and other electronic products. It also offers whole product assembly services to clients. As part of its automobile business, the company manufactures and offers tradi …
  • Hangzhou Tigermed Consulting Co Ltd (300347)：企業の財務・戦略的SWOT分析
    Summary Hangzhou Tigermed Consulting Co Ltd (Tigermed) is a contract research organization (CRO) that provides clinical trial services. It offers regulatory submission and approval, medical translation and GMP (Good Manufacturing Practice) consulting, medical monitoring, project management, medical …
  • Tower International Inc：企業の戦略的SWOT分析
    Tower International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Toromont Industries Ltd：企業の戦略・SWOT・財務情報
    Toromont Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Toromont Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Canada Pension Plan Investment Board：企業の戦略・SWOT・財務情報
    Canada Pension Plan Investment Board - Strategy, SWOT and Corporate Finance Report Summary Canada Pension Plan Investment Board - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Tianda Pharmaceuticals Ltd (455)：企業の財務・戦略的SWOT分析
    Summary Tianda Pharmaceuticals Ltd (Tianda Pharma), a subsidiary of Tianda Group Ltd, is a healthcare supplement product manufacturer that researches, develops, manufactures and markets biotechnology, pharmaceutical and health care products. The company provides products covering various therapeutic …
  • CA Technologies, Inc.：企業の戦略・SWOT・財務情報
    CA Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary CA Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Lego AS：企業の戦略的SWOT分析
    Lego AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • SK Chemicals Co Ltd (006120)：企業の財務・戦略的SWOT分析
    Summary SK Chemicals Co Ltd (SK Chemicals) is a chemical company that provides life sciences products and solutions. The company manufactures polyester and acetate yarns for textile, and industrial uses. Its copolyesters comprise ecozen, skygreen and skypets. SK Chemicals provides high-performance r …
  • Expres2ion Biotechnologies ApS (EXPRS2)：製薬・医療：M&Aディール及び事業提携情報
    Summary Expres2ion Biotechnologies ApS (Expres2ion), a subsidiary of ExpreS2ion Biotech Holding AB is a contract research organization that offers cell lines and processes based on Drosophila S2 cells. The organization develops ExpreS2 expression system, a non-viral insect cell expression system tha …
  • j2 Global, Inc.：企業のM&A・事業提携・投資動向
    j2 Global, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's j2 Global, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • UTC Engenharia SA：企業の戦略的SWOT分析
    UTC Engenharia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆